Aptevo Therapeutics (APVO) Stock: Buy, Sell, or Hold?
$0.59
-0.07 (-10.00%)
▼
5d:
-52.09%
30d:
-65.05%
90d:
-78.86%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$1.24 – $1.77
Position: OVERSOLD
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$25.50
+4192.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.59 / $1.44
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: APVO is down 52.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $0.59, which is considered oversold relative to its 30-day fair value range of $1.24 to $1.77.
Technical Outlook: Technically, APVO is in a strong downtrend. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.0% recently.
Market Sentiment: APVO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.50 (+4192.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APVO is in a strong downtrend. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.0% recently.
Market Sentiment: APVO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.50 (+4192.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.24 -
$1.77
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$1.24 -
$1.77
Current vs Trading Range
OVERSOLD
Support Level
$0.59
Resistance Level
$1.44
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.0%)
- BULLISH: Trading 4192.2% below Wall St target ($25.50)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.06
Wall Street Target
$25.50
(+4192.2%)
Revenue Growth (YoY)
-100.0%
Share APVO Analysis
Share this live APVO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (APVO)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Aptevo Therapeutics raised approximately $3.0 million through the exercise of existing warrants and issued new warrants for 13,888,890 shares. The transaction was facilitated by Roth Capital Partners.
Key Retail Themes:
Financing
Warrant exercise
Dilution
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:54 PM ET
Data refreshes hourly during market hours. Next update: 6:54 PM
Data refreshes hourly during market hours. Next update: 6:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive APVO Research Pages
